{"pmid":32429004,"title":"First organ donation in Wuhan after ending of the coronavirus lockdown.","text":["First organ donation in Wuhan after ending of the coronavirus lockdown.","Organ donation has been suspended for almost 3 months in Wuhan due to COVID-19 outbreak. Donation and transplantation were performed on 8(th) April, the very day Wuhan lifted its lockdown. Two weeks after donation, COVID-19 screenings of the liver recipient and medical staffs present negative.","Transpl Int","Shi, Huibo","Xu, Jing","Li, Xiaoqin","Zhao, Yuanyuan","Wei, Lai","Jiang, Jipin","Chen, Zhishui","32429004"],"abstract":["Organ donation has been suspended for almost 3 months in Wuhan due to COVID-19 outbreak. Donation and transplantation were performed on 8(th) April, the very day Wuhan lifted its lockdown. Two weeks after donation, COVID-19 screenings of the liver recipient and medical staffs present negative."],"journal":"Transpl Int","authors":["Shi, Huibo","Xu, Jing","Li, Xiaoqin","Zhao, Yuanyuan","Wei, Lai","Jiang, Jipin","Chen, Zhishui"],"date":"2020-05-20T11:00:00Z","year":2020,"_id":"32429004","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/tri.13658","keywords":["donation","infection"],"locations":["Wuhan","Wuhan","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1667352728817369088,"score":9.490897,"similar":[{"pmid":32323460,"title":"Solid Organ Transplantation Programs Facing Lack of Empiric Evidence in the COVID-19 Pandemic: A By-proxy Society Recommendation Consensus Approach.","text":["Solid Organ Transplantation Programs Facing Lack of Empiric Evidence in the COVID-19 Pandemic: A By-proxy Society Recommendation Consensus Approach.","The ongoing SARS-CoV-2 pandemic has a drastic impact on national healthcare systems. Given the overwhelming demand of facility capacity, the impact on all healthcare sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of healthcare capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing COVID-19 pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending non-urgent transplant procedures and living donation programs. Systematic PCR-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (e.g., screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach on informed guidance for healthcare management when a priori no scientific evidence is available.","Am J Transplant","Ritschl, Paul Viktor","Nevermann, Nora","Wiering, Leke","Wu, Helen Hairun","Morodor, Philipp","Brandl, Andreas","Hillebrandt, Karl","Tacke, Frank","Friedersdorff, Frank","Schlomm, Thorsten","Schoning, Wenzel","Ollinger, Robert","Schmelzle, Moritz","Pratschke, Johann","32323460"],"abstract":["The ongoing SARS-CoV-2 pandemic has a drastic impact on national healthcare systems. Given the overwhelming demand of facility capacity, the impact on all healthcare sectors has to be addressed. Solid organ transplantation represents a field with a high demand on staff, intensive care units and follow-up facilities. The great therapeutic value of organ transplantation has to be weighed against mandatory constraints of healthcare capacities. In addition, the management of immunosuppressed recipients has to be reassessed during the ongoing COVID-19 pandemic. In addressing these crucial questions, transplant physicians are facing a total lack of scientific evidence. Therefore, the aim of this study was to offer an approach of consensus-based guidance, derived from individual information of 22 transplant societies. Key recommendations were extracted and the degree of consensus among different organizations was calculated. A high degree of consensus was found for temporarily suspending non-urgent transplant procedures and living donation programs. Systematic PCR-based testing of donors and recipients was broadly recommended. Additionally, more specific aspects (e.g., screening of surgical explant teams and restricted use of marginal donor organs) were included in our analysis. This study offers a novel approach on informed guidance for healthcare management when a priori no scientific evidence is available."],"journal":"Am J Transplant","authors":["Ritschl, Paul Viktor","Nevermann, Nora","Wiering, Leke","Wu, Helen Hairun","Morodor, Philipp","Brandl, Andreas","Hillebrandt, Karl","Tacke, Frank","Friedersdorff, Frank","Schlomm, Thorsten","Schoning, Wenzel","Ollinger, Robert","Schmelzle, Moritz","Pratschke, Johann"],"date":"2020-04-24T11:00:00Z","year":2020,"_id":"32323460","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/ajt.15933","topics":["Prevention"],"weight":1,"_version_":1666138493919690752,"score":163.39409},{"pmid":32359194,"title":"COVID-19 In Spain: Transplantation In The Midst Of The Pandemic.","text":["COVID-19 In Spain: Transplantation In The Midst Of The Pandemic.","Spain has been one of the most affected countries by the COVID-19 outbreak. As of 28 April 2020, the number of confirmed cases is 210,773, including 102,548 patients recovered, more than 10,300 admitted to the ICU, and 23,822 deaths, with a global case fatality rate of 11.3%. From the perspective of donation and transplantation, the Spanish system first focused on safety issues, providing recommendations for donor evaluation and testing, and to rule out SARS-CoV-2 infection in potential recipients prior to transplantation. Since the country entered into an epidemiological scenario of sustained community transmission and saturation of intensive care, developing donation and transplantation procedures has become highly complex. Since the national state of alarm was declared in Spain on 13 March 2020, the mean number of donors has declined from 7.2 to 1.2 per day, and the mean number of transplants from 16.1 to 2.1 per day. Increased mortality on the waiting list may become a collateral damage of this terrible pandemic.","Am J Transplant","Dominguez-Gil, Beatriz","Coll, Elisabeth","Fernandez-Ruiz, Mario","Corral, Esther","Del Rio, Francisco","Zaragoza, Rafael","Rubio, Juan Jose","Hernandez, Domingo","32359194"],"abstract":["Spain has been one of the most affected countries by the COVID-19 outbreak. As of 28 April 2020, the number of confirmed cases is 210,773, including 102,548 patients recovered, more than 10,300 admitted to the ICU, and 23,822 deaths, with a global case fatality rate of 11.3%. From the perspective of donation and transplantation, the Spanish system first focused on safety issues, providing recommendations for donor evaluation and testing, and to rule out SARS-CoV-2 infection in potential recipients prior to transplantation. Since the country entered into an epidemiological scenario of sustained community transmission and saturation of intensive care, developing donation and transplantation procedures has become highly complex. Since the national state of alarm was declared in Spain on 13 March 2020, the mean number of donors has declined from 7.2 to 1.2 per day, and the mean number of transplants from 16.1 to 2.1 per day. Increased mortality on the waiting list may become a collateral damage of this terrible pandemic."],"journal":"Am J Transplant","authors":["Dominguez-Gil, Beatriz","Coll, Elisabeth","Fernandez-Ruiz, Mario","Corral, Esther","Del Rio, Francisco","Zaragoza, Rafael","Rubio, Juan Jose","Hernandez, Domingo"],"date":"2020-05-03T11:00:00Z","year":2020,"_id":"32359194","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/ajt.15983","locations":["Spain","Spanish","Spain","Spain"],"countries":["Spain"],"countries_codes":["ESP|Spain"],"topics":["Prevention"],"weight":1,"_version_":1666138495324782592,"score":161.26683},{"pmid":32243255,"title":"Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.","text":["Severe Acute Respiratory Syndrome Coronavirus 2 RNA Detected in Blood Donations.","Because of high rates of 2019 novel coronavirus disease in Wuhan, China, Wuhan Blood Center began screening for severe acute respiratory syndrome coronavirus 2 RNA on January 25, 2020. We screened donations in real-time and retrospectively and found plasma samples positive for viral RNA from 4 asymptomatic donors.","Emerg Infect Dis","Chang, Le","Zhao, Lei","Gong, Huafei","Wang, Lunan","Wang, Lan","32243255"],"abstract":["Because of high rates of 2019 novel coronavirus disease in Wuhan, China, Wuhan Blood Center began screening for severe acute respiratory syndrome coronavirus 2 RNA on January 25, 2020. We screened donations in real-time and retrospectively and found plasma samples positive for viral RNA from 4 asymptomatic donors."],"journal":"Emerg Infect Dis","authors":["Chang, Le","Zhao, Lei","Gong, Huafei","Wang, Lunan","Wang, Lan"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243255","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.3201/eid2607.200839","keywords":["2019 novel coronavirus disease","covid-19","china","sars","sars-cov-2","blood donors","coronavirus","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138492126625792,"score":158.5122},{"pmid":32432804,"title":"Impact of Severe Acute Respiratory Syndrome (SARS) on Blood Services and Blood in Hong Kong in 2003.","text":["Impact of Severe Acute Respiratory Syndrome (SARS) on Blood Services and Blood in Hong Kong in 2003.","The current global pandemic of COVID-19 due to the novel coronavirus SARS-CoV-2 is causing considerable loss of life and enormous social and economic disruption. Here, we describe the response of the blood service, the impact on blood donation and the effects on the blood supply in Hong Kong posed by the earlier SARS epidemic in 2002 and 2003. The infection, like SARS-CoV-2 was highly contagious through droplet transmission. In the 2003 SARS epidemic in Hong Kong, donor and staff safety was secured by using stringent infection control measures to protect both donors and staff from contacting the virus. All the donors were requested to wear face masks within the donation venue and use an alcohol-based hand rinse. The donors' body temperature was checked before donation and staff's body temperatures were checked daily. The safety of the blood supply was secured by a donor deferral policy for 4 weeks following contact with a confirmed or suspected case of and a post-donation call-back system. Despite scheduling mobile donation sessions and a decrease in donors attending blood donor centers, the blood supply was maintained as there was a 12.8% reduction of the demand of blood and only a 16.9% reduction in the blood donation. Lessons learnt during the epidemic may help preparation for future epidemics and provide a basis for understanding the pathogenesis, laboratory diagnosis and role of coronaviruses in transfusion medicine. These are continuing problems as coronavirus epidemics may recur with future impact on blood collection and blood donation screening. This article is protected by copyright. All rights reserved.","Transfus Med","Lee, C K","32432804"],"abstract":["The current global pandemic of COVID-19 due to the novel coronavirus SARS-CoV-2 is causing considerable loss of life and enormous social and economic disruption. Here, we describe the response of the blood service, the impact on blood donation and the effects on the blood supply in Hong Kong posed by the earlier SARS epidemic in 2002 and 2003. The infection, like SARS-CoV-2 was highly contagious through droplet transmission. In the 2003 SARS epidemic in Hong Kong, donor and staff safety was secured by using stringent infection control measures to protect both donors and staff from contacting the virus. All the donors were requested to wear face masks within the donation venue and use an alcohol-based hand rinse. The donors' body temperature was checked before donation and staff's body temperatures were checked daily. The safety of the blood supply was secured by a donor deferral policy for 4 weeks following contact with a confirmed or suspected case of and a post-donation call-back system. Despite scheduling mobile donation sessions and a decrease in donors attending blood donor centers, the blood supply was maintained as there was a 12.8% reduction of the demand of blood and only a 16.9% reduction in the blood donation. Lessons learnt during the epidemic may help preparation for future epidemics and provide a basis for understanding the pathogenesis, laboratory diagnosis and role of coronaviruses in transfusion medicine. These are continuing problems as coronavirus epidemics may recur with future impact on blood collection and blood donation screening. This article is protected by copyright. All rights reserved."],"journal":"Transfus Med","authors":["Lee, C K"],"date":"2020-05-21T11:00:00Z","year":2020,"_id":"32432804","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1111/tme.12698","keywords":["blood safety","blood transfusion","covid-19","coronavirus","sars-cov-2","severe acute respiratory syndrome"],"locations":["China","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"e_drugs":["Alcohols"],"topics":["Prevention"],"weight":1,"_version_":1667342288325443584,"score":158.2789},{"pmid":32368850,"title":"Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors.","text":["Utilization of deceased donors during a pandemic: An argument against using SARS-CoV-2 positive donors.","SARS-CoV-2 has rapidly become an unprecedented pandemic that has impacted society, disrupted hospital functions, strained healthcare resources and impacted the lives of transplant professionals. Despite this, organ failure and the need for transplantation continues throughout the United States. Considering the perpetual scarcity of deceased donor organs, Kates et al present a viewpoint that advocates for the utilization of COVID-19 positive donors in selected cases. We present a review of the current literature that details the potential negative consequences of COVID-19 positive donors. The factors we consider include: 1) the risk of blood transmission SARS-CoV-2, 2) involvement of donor organs, 3) lack of effective therapies, 4) exposure of healthcare and recovery teams, 5) disease transmission and propagation, and 6) hospital resource utilization. While we acknowledge that transplantation fulfills the mission of saving lives, it is imperative to consider the consequences not only to our recipients, but also to the community and to healthcare workers, particularly in the absence of effective preventative or curative therapies. For these reasons, we believe the evidence and risks show that COVID-19 infection should continue to remain a contraindication for donation, as has been the initial response of donation and transplantation societies.","Am J Transplant","Shah, Malay B","Lynch, Raymond J","El-Haddad, Hanine","Doby, Brianna","Brockmeier, Diane","Goldberg, David S","32368850"],"abstract":["SARS-CoV-2 has rapidly become an unprecedented pandemic that has impacted society, disrupted hospital functions, strained healthcare resources and impacted the lives of transplant professionals. Despite this, organ failure and the need for transplantation continues throughout the United States. Considering the perpetual scarcity of deceased donor organs, Kates et al present a viewpoint that advocates for the utilization of COVID-19 positive donors in selected cases. We present a review of the current literature that details the potential negative consequences of COVID-19 positive donors. The factors we consider include: 1) the risk of blood transmission SARS-CoV-2, 2) involvement of donor organs, 3) lack of effective therapies, 4) exposure of healthcare and recovery teams, 5) disease transmission and propagation, and 6) hospital resource utilization. While we acknowledge that transplantation fulfills the mission of saving lives, it is imperative to consider the consequences not only to our recipients, but also to the community and to healthcare workers, particularly in the absence of effective preventative or curative therapies. For these reasons, we believe the evidence and risks show that COVID-19 infection should continue to remain a contraindication for donation, as has been the initial response of donation and transplantation societies."],"journal":"Am J Transplant","authors":["Shah, Malay B","Lynch, Raymond J","El-Haddad, Hanine","Doby, Brianna","Brockmeier, Diane","Goldberg, David S"],"date":"2020-05-06T11:00:00Z","year":2020,"_id":"32368850","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/ajt.15969","locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138496232849409,"score":156.74738}]}